EASL Studio S4E16 - Highlights from the EASL Liver Cancer Summit 2023
S4E16 Promo - Highlights from the EASL Liver Cancer Summit 2023
EASL Studio - S3E16 - Liver cancer in 2022: Wrap-up & outlook
EASL Studio S4 Special Edition - A new strategy for liver cancer screening
EASL Studio S05E1 - What is really new in the EASL CPG on ACLF?
EASL Congress 2023 - Explore the Cirrhosis and Complications track!
EASL Studio - Season 1, Episode 1 - Liver Cancer Awareness Month
Highlights from the EASL NAFLD Summit 2022 - EASL STUDIO Season 3 Episode 4 (September 28)
S4E19 Promo - HDV: The devil becomes treatable
Asian Pacific Association for the Study of Liver (APASL) Webinar May 9 2023
The efficacy and safety of double immunity combined STRIDE regimen in unresectable HCC
ECHO 2023 Session 27: Liver Cancer Surveillance
AACR 2023 highlights on advances in the treatment of hepatocellular carcinoma with Pierce Chow
2018 Cholangiocarcinoma Foundation Annual Conference #21 - Day 2 - Mitochondrial Dysfunction
Josep Llovet, MD
S4-E29.1 - EASL Congress 2023: Presentation on MAESTRO-NASH Phase 3 Results
Panel - Novel Therapeutics in the Post Genomic Age
Josep Llovet, MD, PhD: Pathogenesis of Liver Cancer at AACR 2012
Cancer scientist Josep Llovet discusses research for a liver cancer cure.
Heikenwälder oliver